000022693 000__ 01511cam\a22003855i\4500
000022693 001__ 22693
000022693 003__ SzGeWIPO
000022693 005__ 20240708161900.0
000022693 008__ 990120s1999\\\\xx\\\\\\r\\\\u000\0\eng\d
000022693 035__ $$a(wipo)(CD )99-0130
000022693 035__ $$a(OCoLC)1159933412
000022693 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000022693 043__ $$ae------
000022693 084__ $$a110$$qGB
000022693 1001_ $$aVlies, Rosalinde Van Der,$$eauthor.
000022693 24510 $$aProtection of innovation in the pharmaceutical industry /$$cRosalinde Van Der Vlies.
000022693 264_1 $$a[Place of publication not identified] :$$b[publisher not identified],$$c1999.
000022693 300__ $$a1 volume ([15] pages) ;$$c[28] cm.
000022693 336__ $$atext$$btxt$$2rdacontent
000022693 337__ $$aunmediated$$bn$$2rdamedia
000022693 338__ $$avolume$$bnc$$2rdacarrier
000022693 4901_ $$aBio-Science Law Review ;$$v1998 No 3 pages 87-102
000022693 650_0 $$aPatents$$zEurope.
000022693 650_4 $$aPATENTS : PATENTABILITY : PHARMACEUTICAL PRODUCTS : EUROPEAN UNION
000022693 650_4 $$aPHARMACEUTICAL PRODUCTS : PARALLEL IMPORTS
000022693 650_4 $$aPHARMACEUTICAL INDUSTRY : PROTECTION OF INNOVATION
000022693 650_4 $$aPHARMACEUTICAL PRODUCTS : MARKETING AUTHORISATION : EC
000022693 650_4 $$aPHARMACEUTICAL INDUSTRY : STANDARDISED COMMUNITY LEGISLATION
000022693 651_0 $$aEurope$$xCommerce$$xLaw and legislation.
000022693 7001_ $$aCallens, Stefaa.
000022693 830_0 $$aBio-Science Law Review ;$$v1998 No 3 pages 87-102.
000022693 903__ $$v1$$aBIO-SCIENCE LAW REVIEW
000022693 904__ $$aJournal article
000022693 942__ $$cART$$2ddc
000022693 952__ $$w2006-11-03$$p1999-0130$$r0.00$$u35653$$bMAIN$$10$$kGB 110$$v1999-01-20$$zLIBRARY$$70
000022693 980__ $$aBIB
000022693 999__ $$c24711$$d24711